Skip to content

Clinical trials

Phase 2 Myelodysplastic Syndromes trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 2 Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20111
20123
20142
20161
20182
20191
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Terminated2
Unknown status2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center5
Novartis Pharmaceuticals3
GlaxoSmithKline2
Agios Pharmaceuticals, Inc.1
Samsung Medical Center1
Seoul National University Hospital1
Seoul St. Mary's Hospital1
The Korean Society of Blood and Marrow Transplantation1
Ulsan University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes16
Leukemia, Myeloid, Acute5
Leukemia4
Anemia, Refractory, with Excess of Blasts3
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Chronic-Phase3
Anemia, Aplastic2
Blast Crisis2
Leukemia, Biphenotypic, Acute2
Leukemia, Myelomonocytic, Chronic2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.